Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes

BACKGROUND: Currently, no consensus exists on a model describing endogenous glucose production (EGP) as a function of glucagon concentrations. Reliable simulations to determine the glucagon dose preventing or treating hypoglycemia or to tune a dual-hormone artificial pancreas control algorithm need...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Sci Technol
Autors principals: Wendt, Sabrina Lyngbye, Ranjan, Ajenthen, Møller, Jan Kloppenborg, Schmidt, Signe, Knudsen, Carsten Boye, Holst, Jens Juul, Madsbad, Sten, Madsen, Henrik, Nørgaard, Kirsten, Jørgensen, John Bagterp
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Special Section: Artificial Pancreas: Models, Signals, and Control
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5951032/
https://ncbi.nlm.nih.gov/pubmed/28654314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817693254
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars